C.A. Dovonou’s research while affiliated with University of Parakou and other places

... Condom use was the most widely used means of STI prevention by our study population (79%), as well as by PLHIVs in North Kivu [12]. In Parakou, Benin, condoms were used by 32% of respondents [20]. Condoms are generally well known to the population, thanks to the large posters in our cities and the various audiovisual advertisements broadcast on TV and radio. ...

Reference:

Knowledge, Attitudes, and Practices with Regard to Human Immunodeficiency Virus Infection among Students at the University of Kara

... Thus, most (73% moderate obesity, 89% severe obesity, and 100% morbid obesity) of the participants with obesity were women. This could be explained by factors such as: menopause, physical inactivity, and multiparity but also compliance with an aesthetic reference model [3]- [6], [10]. Some studies have revealed that weight gain is associated with maternity and nurturing, this can explain why women are more obese than men. ...

Reference:

Prevalence and Factors Associated with Grade of Obesity in Selected Health Areas in Yaoundé: A Cross-Sectional Study

... However, there still are no published studies from 34 countries, highlighting ongoing under-reporting and the need to build kidney disease research networks in many parts of Africa ( Fig. 1 and Table 1). 10,17,18 The incidence of NS outside of Africa is approximately 4.7 per 100,000 children (range, 1. 15-16.9). 4 In Africa, the true incidence of NS is unknown because most epidemiology studies do not report the population at risk, have small sample sizes, and typically are singlecenter, retrospective, or cross-sectional designs. NS represents approximately 0.16% to 1.46% of pediatric hospitalizations and approximately 14.6% to 47.1% of all kidney disease reported in Africa. ...

Reference:

Childhood Nephrotic Syndrome in Africa: Epidemiology, Treatment Trends, and Outcomes

... It is therefore important to monitor the hemoglobin level of PLHIV already at the start of TRAV so that the latter is effective and accommodating for the patient, such as the choice of molecules to be prescribed for treatment. Previous data presented an average of 9.30 ± 2.90 g/dl in PLHIV without taking into account the duration of ART [5], and a prevalence of 55.1% in the population of adult PLHIV without taking into account clinical stages of patients [7]. These results from the literature are justifiable by the duration of treatment and the AntiRetrovirals used by PLHIV because anemia can also be caused by ARVs such as Azythromicine (AZT), as well as other antimalarial and anti-malarial drugs, Hepatitis C. ...

Reference:

Prevalence of Anemia among People Living with HIV/AIDS Starting Antiretroviral Therapy in the Era of Dolutegravir in Kinshasa, Democratic Republic of Congo

... Ces derniers ont rapporté que les patients réguliers dans les heures de prise des médicaments de première ligne semblaient être protégés contre la tuberculose multirésistante. Dans la présente enquête, aucune des caractéristiques sociodémographiques étudiées (âge, sexe, niveau socio-économique, niveau d'instruction et état civil) n'était associée à l'échec thérapeutique, et leur proportion est en accord avec le profil habituellement décrit de la tuberculose en général (22,27). ...

Reference:

Facteurs associés à l'échec du traitement initial de la tuberculose pulmonaire dans les Centres de Santé de Diagnostic et Traitement de Kinshasa, RD Congo : étude cas -témoins Risk factors for tuberculosis treatment failure among pulmonary tuberculosis patients in health care center of Kinshasa: a case control study